Atreca (NASDAQ:BCEL – Get Rating) and Mustang Bio (NASDAQ:MBIO – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, analyst recommendations, valuation and institutional ownership. Institutional & Insider Ownership 40.2% of Atreca shares are owned […]